Myriad Wins Gene Patent Ruling from US Appeals Court

16.08.2012 - A federal appeals court on Thursday revived its decision to uphold Myriad Genetics's patents on two genes linked to breast and ovarian cancer, after the U.S. Supreme Court told it...